Automating Actionable Multi-Omics Insights for T-cell Therapy Development
Moonshot startup from UC Berkeley SkyDeck.

We improve the design of T-cell therapies today — to make them more efficient and safer for patients tomorrow.
Get in Touch
Contact us and we will respond promptly.
Our customers love us
  • The Immunarch platform has been incredibly helpful with analyzing and interpreting our immunogenomics data. When I reached out with questions, Vadim (Co-Founder/ CEO ImmunoMind) was very helpful and responsive. I'm grateful to ImmunoMind for making this critical immunogenomics analysis program.

    Senior Researcher, TOP-10 Pharma company
  • Using the Immunarch platform has been extremely helpful in producing beautiful publication ready plots for visualizing how clonotypes change across different timepoints. The platform takes hours off data analysis by providing a tool to easily analyze multiple data files and run biomarker discovery in a very smooth and quick way.
    Molly B. El Alam, MPH
    Research Assistant, Department of Radiation Oncology, The University of Texas M.D. Anderson
  • I used the platform to analyse TCR expression in RNAseq data from human skin. It is very handy even without strong prior knowledge in programming and R!
    Irène Gallais, PhD, MD
    Dermatologist in Besancon University Hospital France, affiliated to CMM, Karolinska Institute, Sweden
  • ImmunArch provided me a great and intuitive platform to analyze my TCRseq data, especially sharing of clones, and TCR similarity index.
    Vincent van Unen, PhD
    Stanford University
Benefits
Design better T-cell therapy
Help medical scientists in decision-making by precisely identifying T-cell subpopulations and their immune profile linked to the drug's efficiency and toxicity
Streamline collaborative work across teams, stages and trials
Accelerate collaboration and communication between medical scientists and bioinformaticians from translational and clinical research groups
Leverage single-cell and bulk multi omics technologies for T-cell therapy development
Extract actionable insights from single-cell and bulk transcriptomics, immunogenomics and other -omics using optimized proprietary technologies
Platform for multi-omics intelligence
ImmunoMind's multi-omics intelligent platform guides translational and clinical research to help design better T-cell therapies using proprietary computational immunology and AI technologies.
Contact us
    •  
Contact us:
2150 Shattuck Ave Penthouse, Suite 1300
ImmunoMind Inc.
Berkeley CA 94704

E-mail: contact@immunomind.io